Basilea partners with Phare Bio to deploy generative AI for antibiotic discovery

Basilea Pharmaceutica (BSLN) announced a strategic partnership with Phare Bio Inc., a Boston-based biotech social venture.

Basilea and Phare Bio enter partnership combining anti-infectives industry expertise with unique AI capabilities for the development of a novel antibiotic

Allschwil, Switzerland, December 11, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage ...
TMCnet

Phare Bio and Basilea Announce Landmark Partnership to Develop Next-Generation Broad-Spectrum Antibiotic Using AI

Phare Bio, a biotech social venture harnessing artificial intelligence to accelerate antibiotic discovery and development, and Basilea Pharmaceutica, a commercial-stage biopharmaceutical company ...
Le Lézard

Phillips, Sing named PHFA 2026 housing policy fellows

The Pennsylvania Housing Finance Agency has named Zachary Phillips and Dr. Evaine K. Sing as its 2026 Kathy A. Possinger ...
Le Lézard

ImpetusDX Introduces IDX Oral Health Microbial Testing Panel to Support More Informed Periodontal Care

With periodontal disease affecting more than four in ten American adults and growing evidence connecting oral bacteria to conditions such as cardiovascular disease, diabetes, and pregnancy ...